Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality.

In contrast, differences in inpatient mortality between alloimmunized and non-alloimmunized patients in the SCD and thalassemia groups did not reach statistical significance ( Table 1 ).

also in 111,027 other papers